Apollo Hospitals Enterprise Ltd. Share Price

Overview

Apollo Hospitals Enterprise Ltd. share price is currently ₹9,102.75, up by ₹451.31 (5.22%) from its previous closing price of ₹8,651.44. The share price has gained 21.77% over the past month and gained 23.85% over the past year. The stock's 52-week low and high are ₹6,582.80 and ₹9,186.53, respectively. Apollo Hospitals Enterprise Ltd. has a market capitalisation of ₹ 1,32,138.82 Cr. The share price was last updated on 20 Nov 2026, 03:55 PM IST.

Apollo Hospitals Enterprise Ltd.
Apollo Hospitals Enterprise Ltd.
APOLLOHOSP
 ₹0.00
 ₹451.31
5.22%
Healthcare
 ₹0.00(%)1D

Updated: 20 Nov 2026, 03:55:56 pm IST

Market Data

Open Price

 ₹8,632.84

Prev. Close

 ₹8,651.44
 ₹8,632.84

Day Low

 ₹9,186.53

Day High

 ₹6,582.80

52 Week Low

 ₹9,186.53

52 Week High

HealthcareHospital & Healthcare Services
CategoryLarge Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

58.38

Sector PE

46.21

PB Ratio

14.40

Sector PB

6.06

EPS

155.93

Dividend Yield

0.27

Today's Volume

1.418 M

5 Day Avg. Volume

683.508 K

PEG Ratio

1.70

Market Cap.

₹ 1,32,138.82 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsFinal Dividend of 200% at ₹10/Share
14-Aug-202614-Aug-2026
DividendsInterim Dividend of 200% at ₹10/Share
16-Feb-202616-Feb-2026
DividendsFinal Dividend of 200% at ₹10/Share
19-Aug-202519-Aug-2025
DividendsInterim Dividend of 180% at ₹9/Share
14-Feb-202515-Feb-2025

Mutual Fund Ownership

Mutual Fund Holder
Sep 26
Shares held
Oct 26
Shares held
SBI Nifty 50 ETF19.96 Lac
19.99 Lac
(0.16%)
HDFC Flexi Cap Fund - Growth10.54 Lac
14.66 Lac
(39.04%)
Axis Large Cap Fund - Regular Plan - Growth10.41 Lac
9.23 Lac
(11.34%)
ICICI Prudential Balanced Advantage Fund - Growth6.97 Lac
8.91 Lac
(27.83%)
ICICI Prudential Multi Asset Allocation Fund - Growth5.16 Lac
7.52 Lac
(45.53%)

About Apollo Hospitals Enterprise Ltd. 👋

Apollo Hospitals Enterprise Limited is an integrated healthcare company. It is engaged in the business of providing hospital services and selling pharma and wellness products through a network of pharmacies, including the operation of multidisciplinary private hospitals, clinics, diagnostic centers and pharmacies. It is engaged in hospitals and hospitals-based services. The Company's segments include Healthcare Services, Retail Health and Diagnostics, Digital Health and Pharmacy Distribution, and Others. The Retail Health and Diagnostics segment include clinics, diagnostics, Spectra, Cradle, Sugar, Dental and Dialysis business. The Digital Health and Pharmacy Distribution segment is engaged in the business of procurement and distribution of pharmaceuticals, fast-moving consumer goods and private label products business from various services using the digital platform. The Company has approximately 10,100 plus beds across 73 hospitals and 6,600 plus pharmacies.

Analyst Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
Neha Gupta

Neha Gupta

21 Nov • 2:48 PM · SEBI-Registered Analyst

Apollo Hospitals Jumps 5.3%: Macquarie Double Upgrade

🏥 Hospital stocks in focus! APOLLOHOSP closed 5.29% higher at ₹9,200 on 20 Nov 2026 and touched a fresh 52-week high, after Macquarie upgraded the stock two notches, from Underperform to Outperform. Max Healthcare (+3.88%) and Narayana Hrudayalaya also moved up. In this opinion, I break down: ✅ Why Macquarie skipped "Neutral" and went straight to Outperform ✅ Reason 1: Earnings estimates appear to have bottomed out and stabilised ✅ Reason 2: New hospital beds are filling up, with utilisation expected to keep improving ✅ Reason 3: Valuation concerns have eased; the early profit drag from new capacity looks largely priced in ✅ Key risks flagged: wider drug price controls, slower ramp-up of new hospitals, and rising costs in the 24/7 pharmacy (HealthCo) segment ✅ What investors can track next: occupancy, revenue per bed and margins in coming quarters The rally came on a strong day for markets, with Nifty up 1.12% to 25,800.60 and FIIs net buyers. 💬 Is India's hospital sector entering a new growth phase, or is the good news already in the price? Share your view in the comments! 📲 For daily market notes, search "Neha Gupta SEBI RA" on Telegram and join the FREE channel. Neha Gupta | SEBI Registered Research Analyst | Reg. No. INH000016542 ⚠️ Disclaimer: This content is for educational purposes only and is not investment advice or a buy/sell recommendation. Investments in the securities market are subject to market risks. Read all related documents carefully before investing.

See More
Palak Jain

Palak Jain

21 Nov • 1:55 PM · SEBI-Registered Analyst

Apollo Hospitals Plans To Add 5,800 Beds

India's healthcare industry is expanding, and Apollo Hospitals is preparing for a major capacity expansion. The company plans to add approximately 5,800 hospital beds over the next five years. But why is this expansion important? APOLLOHOSP Apollo's Q2 FY27 results show that demand for specialised healthcare services is growing. Here are some interesting numbers from the September quarter: - Consolidated revenue increased 23% to ₹7,615 crore. - EBITDA grew 29% to ₹1,191 crore. - Net profit increased 32% to ₹630 crore. - Hospital occupancy improved to 73%, compared with 69% last year. NSE India+1 The company also reported strong growth in specialised treatments: - Oncology: 28% - Gastroenterology: 27% - Urology: 26% - Cardiac sciences: 20% Moneycontrol One important development is its upcoming Gurugram hospital, which is expected to add around 470 beds. However, expansion also comes with challenges. New hospitals require significant investment and time to achieve healthy occupancy and profitability. For Apollo, the real opportunity is to increase capacity while maintaining operating margins. India's healthcare demand is growing. The companies that execute expansion efficiently could benefit from this long-term opportunity. Educational purpose only. Not investment advice. Source: Apollo Hospitals' Q2 FY27 exchange filing and earnings updat

See More
Shivansu Jaiswal

Shivansu Jaiswal

21 Nov • 11:38 AM · SEBI-Registered Analyst

Apollo Hospitals Hits Record High After Macquarie Upgrade

APOLLOHOSP Enterprise Ltd shares surged nearly 5.3% on November 20, 2026, hitting a fresh all-time high of ₹9,205. The rally came after global brokerage firm Macquarie upgraded the stock to 'Outperform' from 'Underperform' and sharply raised its target price to ₹10,500 from ₹6,230, indicating potential upside of around 20.2% from the previous closing price. The company also reported strong Q2 FY27 financial performance, with net profit rising 33.6% year-on-year to ₹660 crore, while revenue increased 23% to ₹7,615 crore. EBITDA grew 28.8% to ₹1,191 crore, supported by improved hospital occupancy and higher patient volumes. The brokerage remains positive on Apollo's growth prospects, citing improving profitability and expansion of hospital capacity. However, rising expansion costs and potential regulatory changes in oncology drug pricing remain key risks for investors to monitor.

See More
Shivansu Jaiswal

Shivansu Jaiswal

21 Nov • 8:23 AM · SEBI-Registered Analyst

Sensex-Nifty Rally, Banking Stocks Lead Gains

1. Sensex and Nifty Extend Rally for Second Consecutive Session Indian equity markets ended Friday's session on a strong note, with the Sensex rising 898 points to close at 83,919.71, while the Nifty 50 gained 286 points to settle at 25,800.60. Banking and financial stocks led the rally, reflecting improved investor confidence. 2. Banking Stocks Lead Market Momentum Banking stocks remained in the spotlight as the Nifty Bank index crossed the 64,000 mark to reach a fresh record high. HDFC Bank, ICICI Bank, Axis Bank and IndusInd Bank witnessed strong buying interest, supported by improved market sentiment and foreign investor inflows. 3. Foreign Investor Buying Supports Indian Equities Foreign portfolio investors have significantly increased their investments in Indian equities during November. Strong FPI inflows, easing crude oil prices and a stronger rupee have helped domestic markets outperform several global markets. 4. Apollo Hospitals and Max Healthcare Gain Attention Healthcare stocks attracted investor interest, with APOLLOHOSP and Max Healthcare emerging among the notable Nifty gainers. Positive analyst commentary and improving sentiment supported buying in the healthcare space.

See More
Hruthik N

Hruthik N

20 Nov • 9:07 PM · SEBI-Registered Analyst

Banks Lead Rally, but Broader-Market Buying Is Selective

APOLLOHOSP - Indian equity markets ended sharply higher on Friday: • Nifty 50 gained 286.30 points (1.12%) to close at 25,800.60. • Sensex rose 897.96 points (1.08%) to settle at 83,919.71. Professional Opinion Banking and healthcare stocks led the rally, with Bank Nifty hitting a fresh record high. Strong foreign investor buying and easing crude oil prices supported sentiment. However, the rally was not broad-based: broader markets remained mixed, with small-cap stocks ending marginally lower. This indicates that buying remained selective despite the strong headline gains. Top Nifty 50 movers • Gainer: Apollo Hospitals, up 5.29%. • Loser: Titan Company, down 1.70%.

See More
Vimal K

Vimal K

20 Nov • 6:37 PM · SEBI-Registered Analyst

NIFTY Breakout on Weekly Charts and a follow up

For the week ending 20 November 2026, the Nifty 50 closed at 25,800.60, gaining 656.30 points (+2.61%) to register its fourth consecutive weekly advance and a nine-month closing high. On weekly charts we see a Trendline Breakout an entire candle body out and a follow up candle. Nifty is facing resistance around 26300 to 26400 Levels from september 2024 and has tested this levels multiple times. A breakout above this levels we may see Nifty making new lifetime highs and 22500 Levels would act as the immedeate support. We see a double bottom where in Nifty is making almost similar lows of 22,182.55 and 22179.90. We also see a bullish RSI divergence has emerged on the Weekly Chart while price printed a lower low or double bottom, the RSI formed a higher low, signaling fading selling pressure and a potential upward reversal. Weekly RSI 14 above 60 indicates a bullish trend and The MACD histogram above zero on the weekly chart is flashing green bars, signaling growing bullish momentum. Weekly Top Gainers : MAXHEALTH, APOLLOHOSP, EICHERMOT. MAXHEALTH

See More

News & Events

Frequently Asked Questions

What is the share price of Apollo Hospitals Enterprise Ltd.?

What is the market cap of Apollo Hospitals Enterprise Ltd.?

Should I buy Apollo Hospitals Enterprise Ltd. stock now?

What is the 52 week high and low of Apollo Hospitals Enterprise Ltd.?

Is the Apollo Hospitals Enterprise Ltd. stock good to buy?

Is Apollo Hospitals Enterprise Ltd. a good buy for the long term?

Is Apollo Hospitals Enterprise Ltd. overvalued or undervalued?

What is the PE and PB ratio of Apollo Hospitals Enterprise Ltd.?

Start Now